Rankin McKenzie Partner, Larry Woolhiser is so pleased to be working with Calla Health, a health technology company centered on sustainably improving women’s access to cancer prevention. They are creating innovations that increase wide scale surveillance of cervical pre-cancers and cancers.
Cervical cancer is the second leading cause of death for women worldwide; 85% of deaths occur in low and middle-income countries (LMICs), despite the fact that well-established interventions exist for pre-invasive disease.
Many low-resource countries lack the health care infrastructure required for the cytology-based screening and referral colposcopic diagnosis that have dramatically reduced the disease burden in wealthier countries. Calla’s vision is to sustainably improve women’s access to cancer prevention.
Please read more about their mission and technology at Calla Health Foundation.
